Apeloa Pharmaceutical: Subsidiary's Deuterated Enzalutamide 15kg/drum API Approved for Registration

Apeloa Pharmaceutical announced that its wholly-owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., received the "Chemical Active Pharmaceutical Ingredient Marketing Application Approval Notification" issued by the National Medical Products Administration for deuterated enzalutamide API, with a specification of 15 kg/barrel, notification number 2026YS00917, and the approval conclusion being that it meets the relevant requirements for drug registration and registration is approved.